Carterharcourt Medical Ltd. - Accounts to registrar (filleted)

REGISTERED NUMBER: 04891918 (England and Wales)

Unaudited Financial Statements

for the Year Ended 30 September 2025

for

Carterharcourt Medical Ltd.

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr W G V Harcourt

Mrs C B Harcourt

SECRETARY:

Mrs C B Harcourt

REGISTERED OFFICE:

The Old Rectory

Church Road

Swindon Village

Gloucester

Gloucestershire

GL51 9RD

REGISTERED NUMBER:

04891918 (England and Wales)

ACCOUNTANTS:

TC Group

Cliffe Hill House

22-26 Nottingham Road

Stapleford

NG9 8AA

FIXED ASSETS

Intangible assets

4

-

Tangible assets

5

2,768

2,813

Investment property

6

825,075

815,000

827,843

817,813

CURRENT ASSETS

Debtors

7

47,575

56,258

Cash at bank

64,062

54,591

111,637

110,849

CREDITORS

Amounts falling due within one year

8

67,617

72,014

NET CURRENT ASSETS

44,020

38,835

TOTAL ASSETS LESS CURRENT
LIABILITIES

871,863

856,648

CREDITORS

Amounts falling due after more than one
year

9

(272,721

)

(272,721

)

PROVISIONS FOR LIABILITIES

(43,247

)

(42,008

)

NET ASSETS

555,895

541,919

CAPITAL AND RESERVES

Called up share capital

11

100

Revaluation reserve

12

127,665

123,914

Retained earnings

428,130

417,905

SHAREHOLDERS' FUNDS

555,895

541,919

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 February 2026 and were signed on its behalf by:

Mr W G V Harcourt - Director

1.	STATUTORY INFORMATION

Carterharcourt Medical Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2013, has now been fully amortised.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on reducing balance and 25% on reducing balance

Tangible assets are initially recorded at cost and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation, less any subsequent depreciation and subsequent accumulated impairment losses.

Investment property

Investment property is included at the open market value of each property as estimated by the Directors as at the Balance Sheet date. The surplus or deficit arising from revaluation is recognised in the Statement of Income and Retained Earnings.

No depreciation is provided on Investment property.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 October 2024

and 30 September 2025

10,000

AMORTISATION

At 1 October 2024

and 30 September 2025

10,000

NET BOOK VALUE

At 30 September 2025

-

At 30 September 2024

-

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 October 2024

21,813

Additions

1,026

At 30 September 2025

22,839

DEPRECIATION

At 1 October 2024

19,000

Charge for year

1,071

At 30 September 2025

20,071

NET BOOK VALUE

At 30 September 2025

2,768

At 30 September 2024

2,813

6.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 October 2024

815,000

Additions

5,075

Revaluations

5,000

At 30 September 2025

825,075

NET BOOK VALUE

At 30 September 2025

825,075

At 30 September 2024

815,000

Fair value at 30 September 2025 is represented by:

£

Valuation in 2021

100,218

Valuation in 2022

45,000

Valuation in 2023

25,000

Valuation in 2024

(5,000

)

Valuation in 2025

5,000

Cost

654,857

825,075

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.9.25

30.9.24

£

Trade debtors

26,919

33,236

Other debtors

20,656

23,022

47,575

56,258

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.9.25

30.9.24

£

Taxation and social security

56,779

55,378

Other creditors

10,838

16,636

67,617

72,014

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

30.9.25

30.9.24

£

Other creditors

272,721

Amounts falling due in more than five years:

Repayable otherwise than by instalments

Property mortgage

272,721

10.	SECURED DEBTS

The following secured debts are included within creditors:

30.9.25

30.9.24

£

Other loans

272,721

11.	CALLED UP SHARE CAPITAL

30.9.25

30.9.24

Ordinary A

48

Ordinary B

48

Ordinary C

1

Ordinary D

1

Ordinary E

1

Ordinary F

1

12.

RESERVES

Revaluation

reserve

£

At 1 October 2024

123,914

P&L - Revaluation movement

3,751

At 30 September 2025

127,665

13.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2025 and 30 September 2024:

30.9.25

30.9.24

£

Mr W G V Harcourt and Mrs C B Harcourt

Balance outstanding at start of year

17,651

(69,018

)

Amounts advanced

147,087

188,101

Amounts repaid

(165,654

)

(101,432

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

(916

)

17,651